GUARDIAN THERAPEUTICS
Guardian Therapeutics believe that the true potential of aptamer therapeutics is virtually unlimited and that we are the company to realize that potential.
GUARDIAN THERAPEUTICS
Industry:
Therapeutics
Founded:
2017-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.guardiantherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
+1 781 918-6580
Email Addresses:
[email protected]
Total Funding:
30 M USD
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Official Site Inspections
http://www.guardiantherapeutics.com Semrush global rank: 1.01 M Semrush visits lastest month: 32.74 K
- Host name: ip-173-201-182-144.ip.secureserver.net
- IP address: 173.201.182.144
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Guardian Therapeutics"
Who We Are | Guardian Therapeutics
Who We Are. Guardian is an independent biotech enterprise specialized in discovery and development of aptamer therapeutics. For general inquiries:See details»
Our People - Guardian Therapeutics
Our People. Our senior leadership team comprises industry veterans with, in aggregate, more than a century of R&D experience across the full spectrum from top 10 pharma companies to โฆSee details»
Guardian Therapeutics - Crunchbase Company Profile โฆ
Guardian Therapeutics is a well-capitalized, privately owned drug discovery & development ventureSee details»
Guardian Therapeutics Inc | LinkedIn
Guardian Therapeutics Inc | 246 followers on LinkedIn. Guardian is an independent, family- and employee-owned biotech enterprise specialized in discovery and development of aptamer therapeutics.See details»
Guardian Therapeutics - MassBio
Guardian Therapeutics is a well-capitalized, privately owned drug discovery & development venture based in Cambridge, MA. We employ advanced aptamer technology to create novel โฆSee details»
Guardian Therapeutics, LLC - Buzzfile
Www.guardiantherapeutics.com: There are 4 Companies located at 101 HARTWELL AVE, Lexington, MA 02421 ... Research, and Management Services sector. This organization has โฆSee details»
Guardian Therapeutics, LLC Company Profile | Lexington, MA ...
Find company research, competitor information, contact details & financial data for Guardian Therapeutics, LLC of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
Guardian Therapeutics - VentureRadar
"Guardian is an independent, family- and employee-owned biotech enterprise specialized in discovery and development of aptamer therapeutics.Aptamers are short nucleic acids that bind โฆSee details»
Guardian Therapeutics - PitchBook
Guardian Therapeutics General Information Description. Operator of a biotechnology company intended to discover and develop aptamer therapeutics. The company develops therapeutic technology from aptamers which are short โฆSee details»
Therapeutic Areas | Guardian Therapeutics
Dermatology. Aptamer with high affinity and specificity for IL23 is currently being evaluated for use in autoimmune skin disease as a topical, selective, immunomodulator with locally restricted โฆSee details»
Guardian Therapeutics Inc. - Overview, Competitors and Decision โฆ
Guardian Therapeutics Inc.is headquartered in United States, Lexington - Find employees, decision makers, competitors and company information. DataLead allows to search for B2B โฆSee details»
Guardian Therapeutics Company Profile -Sales, Contacts, โฆ
This organization has been operating for approximately 7 years. Guardian Therapeutics is estimated to generate $389,496 in annual revenues, and employs approximately 6 people at โฆSee details»
Guardian Therapeutics - Overview, News & Similar companies
View Guardian Therapeutics (www.guardiantherapeutics.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as โฆSee details»
R&D Pipeline - Guardian Therapeutics
*Progress steps: Lead-Op, Preclin Dev, Phase 1, Phase 2, and Phase 3. Aptamer Technology Disease Indication Progress* BT200: VWD type 2B: Phase 3; BT200: Hemophilia A: non-severeSee details»
Guardian Therapeutics LLC (Guardian Therapeutics LLC) - ่ฏ็ฉ็ฎก โฆ
ไบ่งฃGuardian Therapeutics LLC (Guardian Therapeutics LLC)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็๏ผ็พ็ ้ขๅ:่ฟ็ค๏ผๆๆฏๅนณๅฐ:้้ ไฝ่ฏ็ฉๅถ่็ฉ๏ผ่ฏ็ฉ:GRX54๏ผGRX-51ใSee details»
Band Therapeutics | Guardian Therapeutics
BT200 Phase 1 program (NCT04103034) was completed in 4Q20. 112 healthy volunteers in SAD, MAD, relative bioavailability, and pharmacologic challenge studies.See details»
GRX 51 - AdisInsight - Springer
Jul 22, 2021 If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with โฆSee details»
Publications & Presentations | Guardian Therapeutics
Publications โฏ Zhu S, Gilbert JC, Hatala P, et al. The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer. J Thromb Haemost. 2020; 18: โฆSee details»